Biogen reported third quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $9.17 on revenue of $3.6B. Analysts polled by forecast EPS of $8.28 on revenue of $3.54B. That compared to EPS of $7.4 on revenue of $3.44B in the same period a year earlier. The company had reported EPS of $9.15 on revenue of $3.62B in the previous quarter.
Biogen follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Novartis ADR earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.41 on revenue of $12.17B. analysts expected EPS of $1.33 on revenue of $11.71B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
